- Home
- KNSA vs NIC Comparison
KNSA vs NIC Comparison
Compare KNSA & NIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KNSA | NIC |
|---|---|---|
| Founded | 2015 | 2000 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.2B |
| IPO Year | 2018 | 2002 |
Fundamental Metrics
Financial Performance| Metric | KNSA | NIC |
|---|---|---|
| Price | $53.50 | $147.12 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | $60.86 | ★ $175.33 |
| AVG Volume (30 Days) | ★ 778.0K | 142.7K |
| Earning Date | 04-28-2026 | 04-21-2026 |
| Dividend Yield | N/A | ★ 1.00% |
| EPS Growth | ★ 225.00 | 21.49 |
| EPS | 0.27 | ★ 9.78 |
| Revenue | ★ $677,564,000.00 | N/A |
| Revenue This Year | $37.48 | $43.96 |
| Revenue Next Year | $17.87 | $26.91 |
| P/E Ratio | $194.30 | ★ $14.77 |
| Revenue Growth | ★ 60.09 | N/A |
| 52 Week Low | $25.71 | $114.12 |
| 52 Week High | $54.31 | $163.11 |
Technical Indicators
Market Signals| Indicator | KNSA | NIC |
|---|---|---|
| Relative Strength Index (RSI) | 69.49 | 45.85 |
| Support Level | $40.67 | $141.62 |
| Resistance Level | N/A | $148.36 |
| Average True Range (ATR) | 2.24 | 4.18 |
| MACD | 0.97 | -1.01 |
| Stochastic Oscillator | 93.68 | 25.01 |
Price Performance
Historical ComparisonAbout KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.
About NIC Nicolet Bankshares Inc.
Nicolet Bankshares Inc is a United States-based bank holding company's principal business is banking, consisting of lending and deposit gathering, as well as ancillary banking-related products and services, to businesses and individuals of the communities it serves, and the operational support to deliver, fund and manage. It offers a variety of loans, deposits, and related services to business customers especially small and medium-sized businesses and professional concerns, business deposit products, cash management services, international banking services, business loans, lines of credit, commercial real estate financing, construction loans, agricultural real estate or production loans, and letters of credit, as well as retirement plan services.